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Inhibitory neurotransmission is a critical determinant of neuronal
networkgainanddynamicrange,suggestingthatnetworkproperties
are shaped by activity during development. A previous study
demonstrated that sensorineural hearing loss (SNHL) in gerbils leads
to smaller inhibitory potentials in L2/3 pyramidal neurons in the
thalamorecipient auditory cortex, ACx. Here, we explored the
mechanisms that account for proper maturation of g-amino butyric
acid (GABA)ergic transmission. SNHL was induced at postnatal day
(P) 10, and whole-cell voltage-clamp recordings were obtained from
layer2/3pyramidalneuronsinthalamocorticalslicesatP16--19.SNHL
ledtoanincreaseinthefrequencyofGABAzine-sensitive(antagonist)
spontaneous (s) and miniature (m) inhibitory postsynaptic currents
(IPSCs),accompaniedbydiminishedamplitudesandlongerdurations.
Consistent with this, the amplitudes of minimum-evoked IPSCs were
also reduced while their durations were longer. The a1- and b2/3
subunit--speciﬁc agonists zolpidem and loreclezole increased control
but not SNHL sIPSC durations. To test whether SNHL affected the
maturationofGABAergictransmission,sIPSCswererecordedatP10.
These sIPSCs resembled the long SNHL sIPSCs. Furthermore,
zolpidem and loreclezole were ineffective in increasing their
durations. Together,these datastrongly suggest that the presynaptic
release properties and expression of key postsynaptic GABAA
receptor subunits are coregulated by hearing.
Keywords: a1 and b2/3 subunits, auditory cortex, development, GABAA
receptor, hearing impairment
Introduction
Anatomically, inhibitory neocortical networks are outweighed
by their excitatory counterparts by about 1:4, yet, if the
integrity of inhibitory circuits is degraded, even a small amount,
the properties of an entire network can be profoundly affected
(Chagnac-Amitai and Connors 1989; Caspary et al. 1999;
Cherubini and Conti 2001; Korpi et al. 2002; Mody and Pearce
2004; Farrant and Nusser 2005). Detailed studies on the
intrinsic and synaptic properties of the inhibitory interneurons
and their inﬂuence on the pre- as well as postsynaptic gain of
the target cells are imperative for the evaluation of their
contribution to normal development as well as pathological
disorders. In the auditory cortex (ACx), for example, activation
of c-amino butyric acid (GABA) circuits leads to sharpening of
onset responses and excitatory receptive ﬁeld properties
(Muller and Scheich 1988; Wang et al. 2000; Foeller et al.
2001). Such properties and the percepts that they support,
such as speech discrimination in background noise, can be
compromised by hearing loss, and this, in part, is due to
a selective decline in inhibitory synapse function that shapes
sound-driven response properties (Caspary et al. 2005).
The strength of inhibitory postsynaptic currents (IPSCs)
represents, in part, the number of synaptic GABAA receptors
and the speciﬁc array of subunits (Otis et al. 1994; Nusser et al.
1997, 1998). Modulation of the subunit expression and
distribution, therefore, has profound consequences on the
development and plasticity of inhibitory synapses (Fagiolini and
Hensch 2000; Hensch 2005) and neural excitability under both
physiological and pathophysiological conditions. In the mam-
malian brain, the most abundant pentameric receptors are
comprised of a, b, and c subunits; the most common
stoichiometry within the neocortex is 2a:2b:1c (Sieghart
et al. 1999; Mehta and Ticku 1999; Knight et al. 2000).
The developmental expression of speciﬁc receptor subunits,
and their distribution on a single neocortical or hippocampal
neuron, can impart distinct functional properties. For example,
experiments in ‘‘knock-in’’ mice show that while a1 subunits
may participate in cortical plasticity, a2 subunits regulate
neuronal ﬁring (Fagiolini et al. 2004), presumably due to their
abundance at synapses on the axon initial segment of pyramidal
cells (Nusser et al. 1996; Fritschy et al. 1998). The profound
changes in developmental expression of speciﬁc subunits
(Laurie et al. 1992) may also underlie the ontogenic changes
in inhibitory postsynaptic current (IPSC) kinetics (Vicini et al.
2001; Banks et al. 2002; Mody and Pearce 2004; Bosman et al.
2005; Huntsman and Huguenard 2006; Mo ¨ hler 2006; Ing and
Poulter 2007).
Experimental manipulations have shown that inhibitory
neurotransmission is a critical determinant of neuronal
network gain, suggesting that network properties are shaped
by GABAergic transmission (Kilman et al. 2002; Burrone et al.
2002; Turrigiano 2007). Prior studies in the developing ventral
auditory brain stem and midbrain have shown that the loss of
cochlear activity for 1 to several days in vivo leads to a reduction
of inhibitory synaptic gain due to diminished inhibitory
postsynaptic potential (IPSP)/IPSC amplitudes and depolarized
inhibitory reversal potential/current (Kotak and Sanes 1996;
Vale and Sanes 2000). In the inferior colliculus (IC) neurons,
such weakening of IPSCs is characterized by reduced inhibitory
conductance and a compromised chloride cotransporter
function (Vale and Sanes 2000; Vale et al. 2003). Furthermore,
electrophysiological and quantitative electron microscopic
(EM)-immunogold data show that developmental sensorineural
hearing loss (SNHL) leads to a signiﬁcant enhancement in
excitatory synapse function in L2/3 pyramidal neurons of the
ACx mediated by both a-amino-3-hydroxy-5-methyl-4-isoxazo-
lepropionic acid (AMPA) and N-methyl-D-aspartic acid (NMDA)
receptors (Kotak et al. 2005).
The current study addresses the question whether early
auditory experience inﬂuences the development of GABAergic
 2008 The Authors
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which
permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.transmission. Our data show that the amplitudes of IPSCs
decline following developmental SNHL. This was accompanied
by the inability of the GABAA receptor subunits, a1 and b2/3, to
respond to speciﬁc agonists. Moreover, increased frequency of
spontaneous (s) IPSCs and miniature (m) IPSCs indicate parallel
alterations at the presynaptic locus. Anatomically, quantitative
EM-immunocytochemical assays reveal that presynaptic gluta-
mic acid decarboxylase (GAD) increased and postsynaptic b2/3
subunit immunogold counts decreased following SNHL (Sarro
E, Kotak VC, Sanes DH, Aoki C, unpublished data). Additionally,
IPSCs from animals before hearing onset shared characteristics
similar to SNHL IPSCs, including insensitivity to the subunit-
speciﬁc agonists. Thus, SNHL may prevent the normal
maturation of GABAergic transmission in the ACx.
Material and Methods
Surgery for SNHL
All protocols were reviewed and approved by New York University
Institutional Animal Care and Use Committee. As described previously
(Vale and Sanes 2002), cochlear ablations were performed on gerbil
(Meriones unguiculatus) pups at postnatal day 10 (P10), just before
the onset of response to airborne sound. Gerbil pups were anesthetized
(methoxyﬂurane), which was assessed by a lack of toe-pinch response.
Each cochlea was then rapidly removed with a forceps. The wound was
sealed, the pups were placed on a heating pad, and then transferred to
the breeding pair. Pups were then reared for 6--9 days with their
parents under conditions identical to those for control pups. The age of
surgery was chosen based on evidence that anteroventral cochlear
nucleus cell number is unaffected by cochlear ablation after P9
(Tierney and Moore 1997). Cochlea removal was conﬁrmed post
mortem by opening each cochlea under a dissecting microscope and
ﬁnding the absence of cochlear tissue but gel foam in its place.
Thalamocortical Brain Slice Recordings and Pharmacology
Horizontal thalamocortical brain slices that retained the afferent
projection from ventral medial geniculate nucleus (MGv) to the ACx
(thalamorecipient cortex, ACx; Kotak et al. 2005) were generated from
P8--20 gerbils. The artiﬁcial cerebrospinal ﬂuid (ACSF) contained
(in mM): 125 NaCl, 4 KCl, 1.2 KH2PO4, 1.3 MgSO4, 26 NaHCO3,1 5
glucose, 2.4 CaCl2, and 0.4 L-ascorbic acid (pH 7.3 when bubbled with
95% O2--5% CO2). ACSF was superfused in the recording chamber at 3
mL/min at 32 ±1 C. Whole-cell recordings were obtained from layer 2/
3 pyramidal neurons that were located in the thalamorecipient cortex.
Neurons were visually identiﬁed under infrared differential interface
contrast (IR-DIC) optics prior to obtaining a GX seal. The location of
individual neuron cell bodies varied from 125 to 400 lm from the pial
surface. The data in this paper were collected from 104 recordings from
control (n = 43), SNHL (n = 45), and prehearing (n = 16) neurons.
GABAergic Activity and Pharmacological Manipulations
TocharacterizeGABAAreceptor--mediatedsIPSCsandminimum-evoked
(me) IPSCs whole-cell voltage-clamp recordings were made at a band-
widthof10kHz.Theinternalpatchsolutioncontained(inmM):100KCl,
40 K-gluconate, 10 NaCl, 10 [4-(2-hydroxyethyl)-1-piperazineethanesul-
fonic free acid] (HEPES), 4 MgATP, 0.1 ethyleneglycol-bis(2-amino-
ethylether)-N,N,N‘,N‘-tetraacetic acid (EGTA), and 5 lidocaine derivative
QX-314 (pH = 7.2 with KOH). Bipolar platinum wire stimulating
electrodes were placed in the MGv and in upper cortical layer 4 (L4)
approximately 100 lm from the recording site to stimulate the
thalamocortical and intracortical pathways, respectively. These stimu-
lating electrodes were fabricated from 0.004‘‘ diameter teﬂon-coated
platinum wires (A-M systems, Carlsborg, WA) inserted into an approx-
imately 2’’-long double-barrel glass electrode. The tips of the wires were
bared of the teﬂon coat (the exposed tip was 0.002’’ diameter).
To isolate inhibitory GABAergic activity, 6,7-Dinitroquinoxaline-2,3-
dione (DNQX) (20 lM) and 2-amino-5-phosphonopentanoate (AP-5)
(50 lM) were added to the superfusing ACSF to block AMPA and NMDA
receptors, respectively. The drugs were applied for a minimum of 8 min
before recording inhibitory currents. For acquiring sIPSCs and mIPSCs,
at least 10 sweeps of 30-s duration each were acquired for each
neuron at holding potential close to the resting membrane potential;
VHOLD = –60 mV (Kotak et al. 2005). The mIPSC recordings were
obtained in the presence of 1 lM tetrodotoxin (TTX).
Figure 1. SNHL sIPSC amplitudes are smaller and frequency is higher. (A, B) The top
panel(A)shows2sweepsofsIPSCsrecordedinthepresenceofDNQXandAP-5for30
s each in a P17 control neuron (A) and an age-matched SNHL neuron (B) at a holding
potentialof60mV.Inbothcases,eachrecordingwasacquired1minapart.Notethat
amplitudes of sIPSCs in the SNHL neuron are smaller, whereas the frequency is higher.
In both control as well as SNHL recordings, addition of 1 lM GABAzine eliminates
sIPSCs,showingthattheyweremediatedbytheactivationofGABAAreceptors.(C)Bar
graphs summarizing the mean amplitude and frequency of sIPSCs recorded from 11
normal and 12 SNHL neurons. Note that the amplitude of mean sIPSCs is smaller in
SNHL neurons (left panel, ﬁlled bar), whereas the mean frequency of sIPSCs is greater
in SNHL neurons (right panel, ﬁlled bar). In this and all subsequent ﬁgures, asterisks
indicate that the differences are signiﬁcant (for statistics, see Results).
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connections was altered following SNHL, me-IPSCs were recorded in
normal ACSF in voltage-clamp conditions at VHOLD = –60 mV. Incremen-
tal stimulus intensities were delivered to L4 at 0.1 Hz until an evoked
IPSC was discernible (Fig. 2A). Stimulation at this intensity produced
>50% failures in eliciting IPSCs. The absolute stimulus intensity varied
approximately 5% between preparations and ages. Increasing the
minimal intensity by more than 5% decreased the failure rate and
increased the IPSC amplitude and possible polysynaptic innervations.
Therefore, the minimal stimulation intensity was kept constant
throughout each recording. The failure rates were not analyzed.
The function of the 2 GABAA receptor subunits was tested by the use
of agonists. Zolpidem (100 nM, Tocris Biosciences, Bristol, UK) was
applied to test for the presence of the a1 subunits, and loreclezole (10
lM, Tocris Biosciences) was applied to test for the presence of the b2/
3 subunits. These agents were added to ACSF and bath applied for at
least 15 min before recording the effect on sIPSC durations. These data
were separately acquired in 2 second traces; at least 50 traces were
recorded per neuron. Thus, they do not constitute a part of the sIPSC
data on amplitudes and frequency recorded before. To validate that the
recorded postsynaptic currents (sIPSCs, mIPSCs, and me-IPSCs) were
due to GABAA receptor activity, bicuculline (20 lM, BIC methoiodide;
Sigma, St Louis, MO) or GABAzine (500 nM-1lM, Tocris Biosciences)
was applied at the end of some experiments (n = 6).
Data Collection and Analysis
Data were collected using a Macintosh G4 running a custom-designed
IGOR (WaveMetrics, v6.0) macro called SLICE (Kotak et al. 2001).
Evoked synaptic potentials and currents were analyzed off-line using
a 2nd IGOR macro called SLICE ANALYSIS. Analysis was restricted to
IPSC amplitudes that were >6 pA as these events could be reliably
identiﬁed in baseline noise. sIPSC durations were manually analyzed off-
line using the SLICE ANALYSIS program, by superimposing 1-ms vertical
grids on traces. The time between the onset of the falling phase of the
sIPSC and the return of the decay phase of the IPSC to the original
baseline was considered as the total duration (ms). Any sIPSCs (2 or
more) that summated before a single sIPSC decay returned to baseline
were not considered in this analysis. To ascertain changes of sIPSC
durations following experimental and pharmacological manipulations,
analysis was restricted to IPSCs collected separately, majority (95%) of
whose amplitudes varied between 20 and 80 pA (above). Thus, we
biased this analysis such that there was no statistical difference
between the control and SNHL sIPSC amplitudes (ca. 40 pA). This
strategy discounted the amplitude-dependent ﬂuctuations in sIPSC
kinetic properties. Statistical tests (analysis of variance [ANOVA],
Students’ t-test for normally distributed data, or Wilcoxon nonparamet-
ric test for data that were not normally distributed) were performed
using statistical software (JMP, SAS Institute, Cary, NC).
Results
Hearing Loss Alters sIPSCs and mIPSCs
To determine whether hearing loss altered the inhibitory
network properties, we 1st recorded sIPSCs under voltage-
clamp conditions at a holding potential of –60 mV after
blocking ionotropic glutamate receptor transmission. The
results showed that the mean sIPSC frequency was increased
while the mean amplitude was decreased signiﬁcantly in SNHL
neurons. (sIPSC frequency, mean ± standard error of the mean
Figure 2. SNHL sIPSC durations are long. (A) Two sweeps of sIPSCs recorded for 2 s
each in a P17 control (top, 2 gray traces) and an age-matched SNHL neuron (bottom,
blacktraces)ataholdingpotentialof60mV.Eachrecordingwasacquired10sapart.
Note that the durations of sIPSCs in the SNHL neuron are longer. (B) Distribution of all
sIPSCs durations, 528 from 10 control neurons and 582 from 10 SNHL neurons,
showing that the sIPSCs durations in SNHL neurons are signiﬁcantly longer.
Figure 3. SNHL me-IPSC amplitudes are smaller and durations are longer. (A)
Intracortical me-IPSCs were recorded in voltage clamp at VHOLD of 60mV in the
presence of ionotropic glutamate receptor blockers, DNQX and AP-5. me-IPSCs were
elicited by stimulating L4 approximately 100 lm away from the L2/3 recording site at
incremental intensities until the failures were replaced by responses. The intensity at
which minimum IPSCs were discernible from failed responses (gray traces) was then
chosen for successive recordings (black traces). Such minimal stimulation intensity
produced a failure rate of 50% or more. (B) With the same method, note that me-
IPSCs recorded from an age-matched SNHL neuron are smaller and longer (black
traces). (C, D) Bar graphs summarizing the mean amplitude and duration of me-IPSCs
recorded from 10 normal and 11 SNHL neurons. The amplitude of mean me-IPSCs is
smaller in SNHL neurons (top panel, right, ﬁlled bar), whereas the mean duration of
near me-IPSCs is longer in SNHL neurons (bottom, right panel, ﬁlled bar).
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d Kotak et al.[SEM]: control, 2 ± 0.2 Hz vs. SNHL, 4.6 ± 0.2 Hz; t-test, t = 7.1;
degrees of freedom [df] = 22, P = 0.0001; sIPSC amplitude,
mean ± SEM: control, 28 ± 2 pA vs. SNHL, 19 ± 2 Hz; t-test,
t = 2.6; df = 20, P = 0.01; Fig. 1). To further test whether these
changes persisted in complete absence of presynaptic action
potentials, TTX (500 nM) was added at the end of the
recording session in some experiments. These results were
comparable to sIPSCs, in that higher mIPSC frequency was
accompanied by signiﬁcantly reduced amplitudes for SNHL
neurons (mIPSC frequency, mean ± SEM: control, 2.2 ± 0.4 Hz
vs. SNHL, 5.2 ± 0.4 Hz; t-test, t = 4.5; df = 9, P = 0.002; mIPSC
amplitude, mean ± SEM: control, 35 ± 3 pA vs. SNHL, 19 ± 3 Hz;
t-test, t = 3.4; df = 9, P = 0.01; recordings not shown).
Hearing Loss Perturbs sIPSC Kinetics
Among other factors, sIPSC kinetic properties reﬂect
underlying function of an array of GABAA receptor subunits.
To measure durations, we used hundreds of control and SNHL
sIPSCs that were separately recorded in 2-s sessions.
To exclude the sIPSC amplitude-based variation in durations,
we measured sIPSC durations of comparable amplitudes
with an average of about 40 pA. This analysis showed that
sIPSC durations were signiﬁcantly longer in the SNHL group.
(sIPSC duration, mean ms ± SEM: control, 58 ± 4 vs. SNHL, 89 ±
4; t = 5.6; df = 19, P = 0.0004; Fig. 2). The effect of hearing loss
on sIPSC duration was thus independent of amplitudes
because sIPSC amplitudes did not differ between the 2 groups;
hence, it is discounted as a factor for this analysis (sIPSC
amplitudes, mean pA ± SEM: control 39.6 ± 2, SNHL, 40 ± 3.3,
P = 0.9).
Hearing Loss Decreases me-IPSCs
Our previous study showed that hearing loss signiﬁcantly
enhanced putative monosynaptic excitatory input originating
from the MGv to L2/3 (Kotak et al. 2005). To determine
whether the strength of putative monosynaptic inhibitory
inputs from GABAergic interneurons to L2/3 pyramidal
neurons was affected by SNHL, me-IPCSs (me-IPSCs) were
recorded in the presence of blockers of ionotropic glutamate
receptors, DNQX and AP-5. Over 100 intracortically evoked
recordings were obtained from each neuron, of which about
50% responses contained an IPSC. The amplitudes of the 6
smallest me-IPSCs were averaged for each neuron. Comparison
of these me-ISPCs revealed that activation of such putative
unitary afferents produce signiﬁcantly reduced IPSC amplitudes
in SNHL neurons (me-IPSC amplitudes, mean pA ± SEM: normal,
14 ± 1.9 vs. SNHL, 7.7 ± 0.8; Wilcoxon’s test, m
2 = 6.4; df = 20,
P = 0.01; Fig. 3).
Because the duration of sIPSCs differed, we acquired
additional data to compare me-IPSC durations. For this, IPSCs
were examined slightly above minimum thresholds for control
and SNHL neurons for consistent kinetic measurements. The
stimulus intensity was adjusted about 5% above that which
produced a 50% failure rate for these experiments. IPSC
amplitudes between 15 and 40 pA were recorded, and thus, the
mean amplitude did not differ between the 2 groups (near me-
IPSC amplitudes, mean pA ± SEM: control, 20.5 ± 8.7 vs. SNHL,
19.1 ± 2.1, df = 13, P = 0.7). However, the IPSC durations were
signiﬁcantly longer in SNHL neurons (IPSC duration, mean ms ±
SEM: control, 92.5 ± 14.5 vs. SNHL, 156.5 ± 20.4; t = 2.55;
df = 13, P = 0.025; Fig. 3).
Figure 4. SNHL disrupts a1 subunit function.(A) Two sweepsof sIPSCs recorded for 2 s each in a P17 control(top, 2 gray traces)at aholding potentialof 60 mV.Eachrecording
wasacquired10s apart.NotethatGABAAreceptora1subunit--speciﬁcagonist,zolpidem,prolongssIPSCdurations(bottom,2blacktraces).(B)Note thatinanage-matched SNHL
neuron, zolpidem application does not produce an increase in sIPSC durations. (C, D) Distribution of all sIPSCs durations, 470 from 5 control neurons and 572 from 5 SNHL neurons,
showing that the sIPSCs durations are signiﬁcantly prolonged by zolpidem treatment in control neurons but not in SNHL neurons. Horizontal bars indicate mean sIPSC durations.
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If the hearing loss--mediated increase in sIPSC duration involves
a change in the expression of GABAA receptor subunits, then
the efﬁcacy of speciﬁc subunit agonists should be perturbed.
To test this idea, agonists for GABAA receptor subunits known
for their high afﬁnity to the benzodiazapine-binding site
(zolpidem, a1 agonist) or an anticonvulsant site (loreclezole,
b2/3 agonist) were employed. Whereas zolpidem (100 nM)
signiﬁcantly prolonged sIPSC durations in control neurons, the
agonist failed to enhance sIPSC durations in SNHL neurons
(control sIPSC durations, mean ms ± SEM: before zolpidem, 69
± 4 vs. after zolpidem, 114 ± 10; t = 5.6; df = 9, P = 0.003; SNHL
sIPSC durations mean ms ± SEM, before zolpidem, 94 ± 6 vs.
after zolpidem, 102 ± 7, t = 0.8, df = 9, P = 0.4; Fig. 4). Similarly,
bath application of the b2/3 subunit agonist, loreclezole (10
lM), signiﬁcantly lengthened sIPSC durations in control
neurons but did not signiﬁcantly affect sIPSC durations in
SNHL neurons (control sIPSC durations, mean ms ± SEM: before
loreclezole, 49 ± 2 vs. after loreclezole, 97 ± 5, Wilcoxon’s test,
v
2 = 6.8; P = 0.009; SNHL sIPSC durations, mean ms ± SEM:
before loreclezole, 83 ± 3 vs. after loreclezole, 94 ± 12,
Wilcoxon’s test, v
2 = 0.01, P = 0.9; Fig. 5).
We therefore tested the hypothesis that SNHL may perturb
the maturation of processes that underlie shortening of sIPSC
durations following hearing onset. Additional recordings from
animals before hearing onset (prehearing; P8--10) were
therefore performed. The results showed that the sIPSC
durations resembled the prolonged duration sIPSCs in SNHL
neurons, when compared with controls. A 3-way comparison of
means revealed that there was no signiﬁcant difference
between the sIPSC durations between SNHL and prehearing
neurons, while the control sIPSC duration differed signiﬁcantly
from both groups (ANOVA, F = 15.2, df = 27; sIPSC durations,
mean ms ± SEM: prehearing, 90.4 ± 6.5 vs. SNHL, 89 ± 4, t = 0.2,
df = 17, P = 0.8; prehearing, 90.4 ± 6.5 vs. control, 59 ± 3.8;
t = 4.1, df = 17, P = 0.0005, Fig. 6). This effect was independent
of the amplitudes of sIPSCs (ANOVA, F = 0.2, df = 20, P = 0.8).
Recordings of near me-IPSCs from prehearing neurons also
showed that the durations were similar to SNHL me-IPSCs
(IPSC durations, mean ms ± SEM: prehearing, 154.8 ± 19.5 vs.
SNHL, 156.5 ± 20.4, t = 0.061, df = 13, P = 0.95).
To further test whether the reduced sensitivity of the SNHL
sIPSCs to the a1 and b2/3 subunit agonists reﬂects an immature
state, the agents were tested in prehearing neurons. Similar to
SNHL, sIPSCs from prehearing animals did not show a signiﬁcant
change in duration after zolpidem or loreclezole applications
(prehearing sIPSC durations, mean ms ± SEM; before zolpidem,
82.5 ± 4.3 vs. after zolpidem, 84.2 ± 6.0, t-test, t = 0.2, df = 7,
P = 0.8; before loreclezole, 79.0 ± 3.8 vs. after loreclezole,
90.0 ± 7.4, t-test, t = 1.3, df = 7, P = 0.2; Fig. 7).
Figure 8 is a schematic diagram summarizing the present
ﬁndings on GABAergic transmission following SNHL, along with
our previous ﬁndings on changes depicting heightened in-
trinsic and excitatory synaptic properties (Kotak et al. 2005)
Figure 5. SNHL disruptsb2/3subunit function. (A) Twosweeps of sIPSCsrecordedfor2 s each inaP17 control (top, 2 graytraces)ata holdingpotentialof60mV. Eachrecording
wasacquired10sapart.NotethatGABAAreceptorb2/3subunit--speciﬁcagonist,loreclezole,prolongssIPSCdurations(bottom,2blacktraces).(B)Notethatinanage-matchedSNHL
neuron, loreclezole application does not produce an increase in sIPSC durations. (C, D) Distribution of all sIPSCs durations, 564 from 5 control neurons and 608 from 5 SNHL neurons,
showing that the sIPSCs durations are signiﬁcantly prolonged by loreclezole application in control neurons but not in SNHL neurons. Horizontal bars indicate mean sIPSC durations.
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(Sarro E, Kotak VC, Sanes DH, Aoki C, unpublished data).
Discussion
Deafness and GABAergic Properties
Despite the strides made by behavioral and by in vivo
physiology experiments, we are just beginning to understand
the biophysical and synaptic alterations in the ACx that attend
moderate or severe hearing loss. A previous report demon-
strated that SNHL elevates excitability in L2/3 pyramidal
neurons as reﬂected by changes in the passive membrane
properties, increased thalamocortical excitatory drive, and
diminished maximum-evoked IPSPs (Kotak et al. 2005). A
fundamental question is whether inhibitory synapse function is
altered at both pre- and postsynaptic loci. The present study
shows that SNHL prevents the normal maturation of pre-
synaptic release and postsynaptic GABA receptor function.
Speciﬁcally, while the presynaptic terminals may release GABA
more frequently (Fig. 1), the diminished amplitudes of unitary
afferent-evoked inhibitory currents indicate inadequate post-
synaptic GABAA receptor activation (Figs 1--3, Cherubini and
Conti 2001; Nusser et al. 1997, 1998). Futhermore, prolonged
sIPSCs and evoked IPSCs, resembling those recorded in
prehearing animals (P10), suggest that SNHL prevents the
maturation of inhibitory synaptic properties. These altered
IPSC kinetics are well correlated with the diminished efﬁcacy
of the a1 and b2/3 subunit--speciﬁc agonists in SNHL neurons
(Figs 4--5) and prehearing neurons (Fig. 7). We argue that
hearing experience is critical for the emergence of mature pre-
and postsynaptic properties of GABAergic transmission in the
ACx, and this involves key subunits integral to the postsynaptic
GABAA receptors.
Complete hearing loss is expected to affect endogenous
patterns of activity across the ascending auditory pathway and
key integrating elements in the brain stem, midbrain, and
thalamus. For example, prior to the onset of hearing, gerbil IC
neurons display spontaneous activity (Kotak and Sanes 1995).
Maintained discharge at the level of the eighth nerve and
ventral cochlear nucleus (VCN) originates within the cochlea
of adult and juvenile mammals (Bock and Webster 1974;
Koerber et al. 1966; Tucci et al. 1999; Sheperd et al. 1999; Tucci
et al. 2001; Lee et al. 2001; Cook et al. 2002., Yu et al. 2005) and
pre- and posthatched birds (Born and Rubel 1988; Born et al.
1991; Lippe 1994). An alteration in VCN spontaneous activity is
expected to have an impact on IC electrical activity. In the
gerbil, 2-deoxyglucose studies demonstrate that the metabolic
activity is decreased in the contralateral lobe of the IC
following either conductive hearing loss or SNHL, even in
relative silence (Tucci et al. 1999, 2001). Together, these
ﬁndings suggest that cochlear ablation, either in infancy or
adulthood, results in a signiﬁcant loss of peripheral action
potentials and neurotransmission during the period immedi-
ately after ablation, and these factors likely inﬂuenced the
inhibitory properties we assayed in the cortex.
Figure 6. Prehearing IPSC durations are long. (A) Two sweeps of sIPSCs recorded for 2 s each in a P17 SNHL (top, 2 gray traces, taken from Figure 2) and a P10 prehearing
neuron (bottom, 2 black traces) at a holding potential of 60 mV. Each recording was acquired 10 s apart. Note that the durations of sIPSCs in the prehearing neuron are long as
in the SNHL neuron. (B) Distribution of all sIPSCs durations, 582 from 10 SNHL neurons and 469 from 8 prehearing neurons, showing the close resemblance between the sIPSC
durations of prehearing and SNHL neurons. For comparison, see control sIPSC durations in Figure 2.
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and auditory systems indicates downregulation of GABAergic
transmission, and our data concur with these ﬁndings. For
example, blocking action potentials by chronically exposing
cultured neurons with tetrodotoxin leads to a signiﬁcant
decline in mIPSC amplitudes due to a decrease in the average
number of open GABA-gated channels and their inappropriate
clustering at the postsynaptic membrane that includes b
subunits (Kilman et al. 2002). We observed a similar reduction
in the amplitudes of sIPSC and mIPSC in SNHL neurons
suggesting decreased GABAA receptor function is likely
associated with a lower number of GABAA receptors (Nusser
et al. 1997, 1998). The diminished sIPSC and mIPSC and
putative unitary IPSC amplitudes in SNHL neurons (Figs 1 and
2) correspond with a decline in inhibitory conductance in the
IC following bilateral SNHL (Vale and Sanes 2000). It is also
possible that decreased inhibitory response amplitudes were
due to depolarization of the IPSP reversal potential as shown in
the lateral superior olivary and IC neurons (Kotak and Sanes
1996; Vale and Sanes 2000; Vale et al. 2003), although we did
not test this. Similarly, weakened connections between fast-
spiking GABAergic interneurons and star pyramidal neurons are
observed in L4 of visually deprived animals (Maffei et al. 2004).
Our observations may additionally explain the reduced
amplitude IPSPs when maximum number of afferents are
activated (Kotak et al. 2005).
Our data also suggest that at the presynaptic level, SNHL
neurons appear to release more GABA (Fig. 1; and increased
mIPSCsfrequency,results),andthiscorrelateswithasigniﬁcantly
enhanced GAD immunoreactivity quantiﬁed ultrastructurally at
the inhibitory terminals that impinge on L2/3 pyramidal neurons
(Sarro E, Kotak VC, Sanes DH, Aoki C, unpublished data). In lieu
ofanenhancedpresynapticGABAreleaseprobaility, itispossible
thatthealteredkineticsinsIPSCsweobservemayadditionallybe
caused by postsynaptic GABAA receptor desensitization (Jones
and Westbrook 1995), although this hypothesis remains to be
tested.
Development and GABAergic Properties
The strong resemblance of sIPSC characteristics in SNHL
neurons with those recorded before hearing onset (Fig. 6)
implies an arrest in the normal expression of GABAergic
transmission at pre- and postsynaptic loci. We found that SNHL
leads to longer duration sIPSCs (Fig. 2) and near me-IPSCs (Fig.
3), which resemble long IPSCs before hearing onset (Fig. 6).
Developmental shortening of IPSCs is consistent with long
mIPSCs recorded during early development from rat cerebellar
granule cell and mouse cerebellar stellate neurons (Tia et al.
1996; Nusser et al. 1997, Vicini et al. 2001). In stellate neurons,
for example, mIPSCs at P11 are long, whereas at P35, they
decay 5 times faster (Vicini et al. 2001).
Figure 7. Prehearing IPSC durations are insensitive to a1 and b2/3 subunit agonists. (A) Two sweeps of sIPSCs recorded for 2 s each in a P10 prehearing neuron (top, 2 gray
traces) at a holding potential of 60 mV. Each recording was acquired 10 s apart. Note that the GABAA receptor a1 subunit--speciﬁc agonist, zolpidem, does not prolong sIPSC
durations (2 black traces). (B) Note that in another age-matched prehearing neuron, the application of the b2/3 agonist, loreclezole, does not prolong sIPSC durations. (C, D)
Distribution of all sIPSC durations, from all prehearing neurons showing that the sIPSCs durations are not prolonged by zolpidem (581 sIPSCs from 4 neurons) or loreclezole (544
sIPSCs from 4 neurons). This result is similar to that obtained for SNHL neurons (see Figs 4 and 5).
2104 Deafness Disrupts Inhibitory Transmission
d Kotak et al.The subunit-speciﬁc agonists zolpidem for a1 subunits
(Pritchett and Seeburg 1990; Wafford et al. 1994; Luddens
et al. 1995; Rudolph and Mo ¨ hler 2004) and loreclezole for b2/3
subunits (Wingrove et al. 1994; Bacci et al. 2003) target GABAA
receptor subunits that affect IPSC kinetics. Both a1 and b2/3
subunits are activated by synaptically released GABA (Amin and
Weiss 1993; Connolly et al. 1996; Baumann et al. 2003).
Functions of these subunits in L2/3 pyramidal neurons can be
assayed by the magnitude of effect of these 2 agents, which act
to enhance IPSC durations (Figs 4 and 5, Bacci et al. 2003).
Importantly, these agents can be used to assess whether the
subunit expression undergoes developmental changes in
parallel to the alterations in the amplitudes and kinetics of
IPSCs. For example, in cerebellar inhibitory synapses, mIPSCs
recorded in a1 subunit--deﬁcient mice at P35 are as slow as
those at P11 suggesting that lack of a1 subunit insertion in
postsynaptic receptors is responsible for the prolonged in-
hibitory synaptic currents. Also, in recombinant systems, rapid
application of GABA to outside-out excised patches generates
faster currents with a1b2c2 than with other subunit combina-
tions (Verdoorn 1994; Gingrich et al. 1995; Lavoie et al. 1997;
McClellan and Twyman 1999), which agrees with the pre-
dominant stoichiometry (a1b2c2) of the GABAA receptor in
mammalian cortex (Korpi et al. 2002; Mo ¨ hler 2006; Huntsman
and Huguenard 2006). Similarly, a progressive shortening of
mIPSCs in thalamic relay neurons during the 1st postnatal
month is accompanied by an increased expression of a1
subunit transcripts and decrease in the a2 transcripts. Further,
thalamic organotypic cultured neurons with an overexpressed
a1 subunit showed faster mIPSCs (Okada et al. 2000). Similar to
the a1 subunit, the b2/3 subunits may emerge during postnatal
development. For example, IPSC sensitivity to loreclezole
increases across postnatal life in rat dentate granule cells
(Kapur and MacDonald 1999), rat medial septum/diagonal band
neurons (Hsiao et al. 1998), and mouse cerebellar granule
cultured neurons (Ortinski et al. 2004). In fact, the de-
velopmental upregulation of b2/3 subunit function may
depend on a1 subunit expression; the effect of loreclezole is
Figure 8. Summary sketch of a L2/3 SNHL pyramidal neuron. This sketch highlights the present ﬁndings that hearing loss leads to alterations in inhibitory synaptic properties (top
right panel, gray). Further, they accompany coadjustments in the passive and active intrinsic (bottom panel) and excitatory synaptic properties (bottom left panel). An upward
arrow indicates increased whereas a downward arrow indicates decreased function. For example, SNHL caused a rise in resting membrane potential (VREST), ﬁring properties, and
input resistance (RINPUT; bottom panel; Kotak et al. 2005). For thalamocortical synapses, SNHL decreased the release probability (mEPSC frequency), whereas increasing mEPSC
and thalamically evoked minimum-EPSC amplitudes and enhancing current carried by the NR2B subunits of the NMDA receptor (left panel). In contrast, the present study shows
increased GABA release probability (higher sIPSCs and mIPSCs frequency) is accompanied by a decrease in sIPSC and me-IPSC amplitudes. Further, an inability of a1 and b2/3
subunit--speciﬁc agonists to alter sIPSCs recorded from SNHL and prehearing neurons sugests an arrest in the maturation of GABAergic transmission. The bottom right panel
(dashed box) displays an observation derived from EM-immunocytochemistry (Sarro E, Kotak VC, Sanes DH, Aoki C, unpublished data) that postsynaptic b2/3 subunit distribution
is disrupted. In addition, the presynaptic terminals may synthesize/release more GABA. The cumulative outcome of such robust homeostatic alterations following hearing loss may
adjust the cortical network at a new set point in anticipation that peripheral activity will be restored.
Cerebral Cortex September 2008, V 18 N 9 2105compromised in IPSCs from a1 subunit –/– mice (Ortinski et al.
2004).
Consistent with these studies, our data also suggest that the
a1 and b2/3 subunits are upregulated during development.
This is shown by the signiﬁcant augmentation of sIPSCs in
control P17--19 neurons by zolpidem and loreclezole and in
contrast the inability of these agonists to potentiate sIPSC
durations in prehearing animals (Fig. 6). Similarly, the inability
of zolpidem and loreclezole to augment SNHL sIPSCs strongly
implies that SNHL may halt the normal expression of the a1 and
b2/3 subunits on L2/3 cells that otherwise would impart
shorter IPSC kinetics (Fig. 2, Okada et al. 2000; Banks et al.
2002; Amin and Weiss 1993; Wafford et al. 1994; Gingrich et al.
1995; Jones and Westbrook, 1995; Baumann et al. 2003).
Signiﬁcantly lower b2/3 immunogold counts observed in SNHL
neurons at the normal postsynaptic membraneous site supports
this deduction (Sarro E, Kotak VC, Sanes DH, Aoki C,
unpublished data). Importantly, similar to an area-speciﬁc
expression of the a1 subunits in developing rat neocortex that
may be mediated via activity (Paysan et al. 1997), the
expression and proper distribution of the a1 and b2/3 subunits
appear to be regulated by auditory activity.
The prolonged sIPSCs observed in prehearing animals and
the inability of the subunit-speciﬁc agonists to affect their
durations implies that a1 and b2/3 are not predominantly
expressed in the ACx before hearing onset. This raises an
important question: what other subunits may underlie such
long IPSCs that may persist in an absence of acoustically driven
activity? It is known that the developmental expression of the
a1 subunit mRNA in the cerebellum is very low during early life
(Bovolin et al. 1992; Laurie et al. 1992). Other subunits such as
a5 (Dunning et al. 1999), a2, and a3 are likely to mediate long
sIPSCs similar to those found early in development. As a matter
of fact, mRNA for a2 and a3 subunits are observed in early
development (Laurie et al. 1992).
Cortical Excitability and GABAergic Properties
The coadjustments of GABAergic function at pre- and post-
synaptic loci are in contrast with the ampliﬁed strength of the
thalamocortical synapses following SNHL. Decreased probabil-
ity of glutamate release (miniature excitatory postsynaptic
currents [mEPSCs]) was accompanied by increased AMPAergic
and NMDAergic participation (me-EPSCs) and higher NR2B
immunogold counts at the asymmetric synapses (Kotak et al.
2005). Coupled with altered membrane properties favoring
heightened excitability, the signiﬁcant decline in postsynaptic
GABAergic function may support higher discharge rates and
thus alter the network properties of the ACx. Figure 8 shows
a diagrammatic sketch of a L2/3 pyramidal SNHL neuron
summarizing the present and previous ﬁndings. Although this
model represents synaptic and biophysical properties following
SNHL, it may apply to a range of conditions that decrease
sound-evoked activity (e.g., the hair cell loss due to ototoxic
drugs, aging, or noise-induced trauma, Syka 2002; Ling et al.
2005). Such weakened inhibition may eventually lead to ﬂawed
communication among neurons and a disorganized tonotopy
(Kaur et al. 2004). For example, even mild to moderate forms of
conductive hearing loss produces synaptic modiﬁcations
within the ACx (Xu et al. 2007), and reduced GABAergic
transmission may contribute. The current ﬁndings may also
explain, in part, the changes that result from partial hair cell
damage including the unmasking of excitatory sidebands and
discharge characteristics (Irvine and Rajan 1997; Rajan 1998;
Salvi et al. 2000; Wang, Ding, et al. 2002; Wang, McFadden, et al.
2002). Diminished inhibitory transmission may also contribute
to temporal jitter to acoustic cues; for example, both the
excitatory synaptic and spike precision are compromised at
auditory nerve--bushy cell synapses in the cochlear nucleus of
early-onset hearing-impaired mice (Wang and Manis 2005). The
net effects of such pre- and postsynaptic modiﬁcations upon
ACx networks and their input--output functions remain to be
identiﬁed. The overall downscaling of inhibitory gain shown for
SNHL neurons may be associated with various clinical
conditions such as epilepsy, tinnitus, and presbycusis that are
also characterized by reduced GABAergic gain. In addition to
the use of implant-based prostheses, attempts to design
targeted drugs with speciﬁc afﬁnity toward distinct GABAA
receptor subunits holds potential to alleviate deﬁcits for the
hearing impaired.
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